{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T21:56:40Z","timestamp":1777413400444,"version":"3.51.4"},"reference-count":12,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.cmi.2019.04.022","type":"journal-article","created":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T12:18:47Z","timestamp":1556281127000},"page":"922-924","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Antibiotic-sparing agents for uncomplicated cystitis: uva-ursi and ibuprofen not ready for primetime"],"prefix":"10.1016","volume":"25","author":[{"given":"R.","family":"Datta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Juthani-Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2019.04.022_bib1","first-page":"21","article-title":"Management of urinary tract infections: historical perspective and current strategies: part 1\u2014before antibiotics","volume":"173","author":"Nickel","year":"2005","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.cmi.2019.04.022_bib2","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1001\/jama.2016.16141","article-title":"Effect of cranberry capsules on bacteriuria plus pyuria among older women in nursing homes: a randomized clinical trial","volume":"316","author":"Juthani-Mehta","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2019.04.022_bib3","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrmicro3432","article-title":"Urinary tract infections: epidemiology, mechanisms of infection and treatment options","volume":"13","author":"Flores-Mireles","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.cmi.2019.04.022_bib4","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.cmi.2019.01.011","article-title":"Uva-ursi extract and ibuprofen as alternative treatments for uncomplicated urinary tract infection in women (ATAFUTI): a factorial randomized trial","volume":"25","author":"Moore","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.04.022_bib5","article-title":"Symptomatic treatment of uncomplicated lower urinary tract infections in the ambulatory setting: randomised, double blind trial","volume":"359","author":"Kronenberg","year":"2017","journal-title":"BMJ (Clinical Research ed.)"},{"key":"10.1016\/j.cmi.2019.04.022_bib6","doi-asserted-by":"crossref","first-page":"h6544","DOI":"10.1136\/bmj.h6544","article-title":"Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial","volume":"351","author":"G\u00e1gyor","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2019.04.022_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002569","article-title":"Ibuprofen versus pivmecillinam for uncomplicated urinary tract infection in women\u2014a double-blind, randomized non-inferiority trial","volume":"15","author":"Vik","year":"2018","journal-title":"PLOS Med"},{"key":"10.1016\/j.cmi.2019.04.022_bib8","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2296-14-71","article-title":"Women with symptoms of uncomplicated urinary tract infection are often willing to delay antibiotic treatment: a prospective cohort study","volume":"14","author":"Knottnerus","year":"2013","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.cmi.2019.04.022_bib9","first-page":"729","article-title":"Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women","volume":"52","author":"Christiaens","year":"2002","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.cmi.2019.04.022_bib10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/bmj.38496.452581.8F","article-title":"Response to antibiotics of women with symptoms of urinary tract infection but negative dipstick urine test results: double blind randomised controlled trial","volume":"331","author":"Richards","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2019.04.022_bib11","doi-asserted-by":"crossref","first-page":"c199","DOI":"10.1136\/bmj.c199","article-title":"Effectiveness of five different approaches in management of urinary tract infection: randomised controlled trial","volume":"340","author":"Little","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2019.04.022_bib12","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1139\/Y07-106","article-title":"In\u00a0vitro activity of uva-ursi against cytochrome P450 isoenzymes and P-glycoprotein","volume":"85","author":"Chauhan","year":"2007","journal-title":"Can J Physiol Pharmacol"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19301995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19301995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:23:31Z","timestamp":1761117811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X19301995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1198743X19301995"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2019.04.022","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibiotic-sparing agents for uncomplicated cystitis: uva-ursi and ibuprofen not ready for primetime","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2019.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2019.01.011","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}